An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome

Thakur, P., Lackinger, M., Diamantopoulou, A., Rao, S., Chen, Y., Khalizova, K., Ferng, A., Mazur, C., Kordasiewicz, H., Shprintzen, R. J., Markx, S., Xu, B., & Gogos, J. A. (2025). An antisense oligonucleotide-based strategy to ameliorate cognitive dysfunction in the 22q11.2 Deletion Syndrome. ELife, 13. CLOCKSS. https://doi.org/10.7554/elife.103328
Authors:
Pratibha Thakur
Martin Lackinger
Anastasia Diamantopoulou
Sneha Rao
Yijing Chen
Khakima Khalizova
Annie Ferng
Curt Mazur
Holly Kordasiewicz
Robert J Shprintzen
Sander Markx
Bin Xu
Joseph A Gogos
Affiliated Authors:
Pratibha Thakur
Martin Lackinger
Anastasia Diamantopoulou
Sneha Rao
Yijing Chen
Khakima Khalizova
Sander Markx
Bin Xu
Joseph A Gogos
Author Keywords:
22q11.2 deletion
schizophrenia
mirna dysregulation
emc10
human ipsc
antisense oligonucleotides
precision psychiatry
human
mouse
neuroscience
Publication Type:
Article
Unique ID:
10.7554/elife.103328
PMID:
Journal:
Publication Date:
Data Source:
PubMed

Record Created: